BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 30954717)

  • 1. Clinical features and outcomes of young patients with epithelioid sarcoma: an analysis from the Children's Oncology Group and the European paediatric soft tissue Sarcoma Study Group prospective clinical trials.
    Spunt SL; Francotte N; De Salvo GL; Chi YY; Zanetti I; Hayes-Jordan A; Kao SC; Orbach D; Brennan B; Weiss AR; van Noesel MM; Million L; Alaggio R; Parham DM; Kelsey A; Randall RL; McCarville MB; Bisogno G; Hawkins DS; Ferrari A
    Eur J Cancer; 2019 May; 112():98-106. PubMed ID: 30954717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study.
    Spunt SL; Million L; Chi YY; Anderson J; Tian J; Hibbitts E; Coffin C; McCarville MB; Randall RL; Parham DM; Black JO; Kao SC; Hayes-Jordan A; Wolden S; Laurie F; Speights R; Kawashima E; Skapek SX; Meyer W; Pappo AS; Hawkins DS
    Lancet Oncol; 2020 Jan; 21(1):145-161. PubMed ID: 31786124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG).
    Ferrari A; van Noesel MM; Brennan B; Zanetti I; Corradini N; Casanova M; Berlanga P; Merks JHM; Alaggio R; Schifflers S; Ramirez-Villar GL; Giraudo C; Burrieza GG; Safwat A; Bisogno G; De Salvo GL; Orbach D
    Lancet Child Adolesc Health; 2021 Aug; 5(8):546-558. PubMed ID: 34214481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph node metastases in paediatric and young adult patients with non-rhabdomyosarcoma soft tissue sarcoma (NRSTS): Findings from Children's Oncology Group (COG) study ARST0332.
    Alvarez E; He J; Spunt SL; Hayes-Jordan A; Kao SC; Parham DM; Million L; Weiss AR; Barkauskas DA
    Eur J Cancer; 2023 Feb; 180():89-98. PubMed ID: 36566574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial.
    Issels RD; Lindner LH; Verweij J; Wessalowski R; Reichardt P; Wust P; Ghadjar P; Hohenberger P; Angele M; Salat C; Vujaskovic Z; Daugaard S; Mella O; Mansmann U; Dürr HR; Knösel T; Abdel-Rahman S; Schmidt M; Hiddemann W; Jauch KW; Belka C; Gronchi A;
    JAMA Oncol; 2018 Apr; 4(4):483-492. PubMed ID: 29450452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors-A Scandinavian Sarcoma Group study (SSG XX).
    Sundby Hall K; Bruland ØS; Bjerkehagen B; Zaikova O; Engellau J; Hagberg O; Hansson L; Hagberg H; Ahlström M; Knobel H; Papworth K; Zemmler M; Goplen D; Bauer HCF; Eriksson M
    Eur J Cancer; 2018 Aug; 99():78-85. PubMed ID: 29929092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgery alone is sufficient therapy for children and adolescents with low-risk synovial sarcoma: A joint analysis from the European paediatric soft tissue sarcoma Study Group and the Children's Oncology Group.
    Ferrari A; Chi YY; De Salvo GL; Orbach D; Brennan B; Randall RL; McCarville MB; Black JO; Alaggio R; Hawkins DS; Bisogno G; Spunt SL
    Eur J Cancer; 2017 Jun; 78():1-6. PubMed ID: 28391003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excellent local control with IOERT and postoperative EBRT in high grade extremity sarcoma: results from a subgroup analysis of a prospective trial.
    Roeder F; Lehner B; Schmitt T; Kasper B; Egerer G; Sedlaczek O; Grüllich C; Mechtersheimer G; Wuchter P; Hensley FW; Huber PE; Debus J; Bischof M
    BMC Cancer; 2014 May; 14():350. PubMed ID: 24885755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma.
    Schmitt T; Lehner B; Kasper B; Bischof M; Roeder F; Dietrich S; Dimitrakopoulou-Strauss A; Strauss LG; Mechtersheimer G; Wuchter P; Ho AD; Egerer G
    BMC Cancer; 2011 Dec; 11():510. PubMed ID: 22152120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of Relevant Clinicopathologic Variables in Epithelioid Sarcoma: A Multi-Institutional Retrospective Study of 44 Patients.
    Asano N; Yoshida A; Ogura K; Kobayashi E; Susa M; Morioka H; Iwata S; Ishii T; Hiruma T; Chuman H; Kawai A
    Ann Surg Oncol; 2015 Aug; 22(8):2624-32. PubMed ID: 25663591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial.
    Weiss AR; Chen YL; Scharschmidt TJ; Chi YY; Tian J; Black JO; Davis JL; Fanburg-Smith JC; Zambrano E; Anderson J; Arens R; Binitie O; Choy E; Davis JW; Hayes-Jordan A; Kao SC; Kayton ML; Kessel S; Lim R; Meyer WH; Million L; Okuno SH; Ostrenga A; Parisi MT; Pryma DA; Randall RL; Rosen MA; Schlapkohl M; Shulkin BL; Smith EA; Sorger JI; Terezakis S; Hawkins DS; Spunt SL; Wang D
    Lancet Oncol; 2020 Aug; 21(8):1110-1122. PubMed ID: 32702309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alveolar soft part sarcoma in children and adolescents: The European Paediatric Soft Tissue Sarcoma study group prospective trial (EpSSG NRSTS 2005).
    Brennan B; Zanetti I; Orbach D; Gallego S; Francotte N; Van Noesel M; Kelsey A; Casanova M; De Salvo GL; Bisogno G; Ferrari A
    Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adolescents and young adults with rhabdomyosarcoma treated in the European paediatric Soft tissue sarcoma Study Group (EpSSG) protocols: a cohort study.
    Ferrari A; Chisholm JC; Jenney M; Minard-Colin V; Orbach D; Casanova M; Guillen G; Glosli H; van Rijn RR; Schoot RA; Cameron AL; Rogers T; Alaggio R; Ben-Arush M; Mandeville HC; Devalck C; Defachelles AS; Coppadoro B; Bisogno G; Merks JHM
    Lancet Child Adolesc Health; 2022 Aug; 6(8):545-554. PubMed ID: 35690071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of soft tissue sarcomas in first isolated local recurrence: a retrospective study of 83 cases].
    Moureau-Zabotto L; Thomas L; Bui BN; Chevreau C; Stockle E; Martel P; Bonneviale P; Marques B; Coindre JM; Kantor G; Matsuda T; Delannes M
    Cancer Radiother; 2004 Oct; 8(5):279-87. PubMed ID: 15561593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and outcomes of young patients with low-grade non-rhabdomyosarcoma soft tissue sarcomas treated with a risk-based strategy: A report from Children's Oncology Group study ARST0332.
    Douglass DP; Coffin CM; Randall RL; Yang Y; Barkauskas DA; Million L; McCarville MB; Pappo AS; Weiss AR; Spunt SL
    Pediatr Blood Cancer; 2024 May; ():e31062. PubMed ID: 38757485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of extracranial malignant rhabdoid tumours in children registered in the European Paediatric Soft Tissue Sarcoma Study Group Non-Rhabdomyosarcoma Soft Tissue Sarcoma 2005 Study-EpSSG NRSTS 2005.
    Brennan B; De Salvo GL; Orbach D; De Paoli A; Kelsey A; Mudry P; Francotte N; Van Noesel M; Bisogno G; Casanova M; Ferrari A
    Eur J Cancer; 2016 Jun; 60():69-82. PubMed ID: 27082136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Experience with Advanced/Metastatic Epithelioid Sarcoma Patients Treated in Prospective Trials: Clinical Profile and Response to Systemic Therapy.
    Touati N; Schöffski P; Litière S; Judson I; Sleijfer S; van der Graaf WT; Italiano A; Isambert N; Gil T; Blay JY; Stark D; Brodowicz T; Marréaud S; Gronchi A
    Clin Oncol (R Coll Radiol); 2018 Jul; 30(7):448-454. PubMed ID: 29550245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelioid sarcoma: the clinicopathological complexities of this rare soft tissue sarcoma.
    Spillane AJ; Thomas JM; Fisher C
    Ann Surg Oncol; 2000 Apr; 7(3):218-25. PubMed ID: 10791853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients.
    Longhi A; Bielack SS; Grimer R; Whelan J; Windhager R; Leithner A; Gronchi A; Biau D; Jutte P; Krieg AH; Klenke FM; Grignani G; Donati DM; Capanna R; Casanova J; Gerrand C; Bisogno G; Hecker-Nolting S; De Lisa M; D'Ambrosio L; Willegger M; Scoccianti G; Ferrari S
    Eur J Cancer; 2017 Mar; 74():9-16. PubMed ID: 28167373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of postoperative complications and functional impairment after multimodality treatment for limb and trunk wall soft-tissue sarcoma: Long term results from a monocentric series.
    Stoeckle E; Michot A; Rigal L; Babre F; Sargos P; Henriques de Figueiredo B; Brouste V; Italiano A; Toulmonde M; Le Loarer F; Kind M
    Eur J Surg Oncol; 2017 Jun; 43(6):1117-1125. PubMed ID: 28202211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.